Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells

14Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

The induction of relatively weak immunity by DNA vaccines in humans can be largely attributed to the low efficiency of transduction of somatic cells. Although formulation with liposomes has been shown to enhance DNA transduction of cultured cells, little, if any, effect is observed on the transduction of somatic tissues and cells. To improve the rate of transduction, DNA vaccine delivery by gene gun and the recently developed electroporation techniques have been employed. We report here that to circumvent requirement for such equipment, amiloride, a drug that is prescribed for hypertension treatment, can accelerate plasmid entry into antigen presenting cells (APCs) both in vitro and in vivo. The combination induced APCs more dramatically in both maturation and cytokine secretion. Amiloride enhanced development of full CD8 cytolytic function including induction of high levels of antigen specific CTL and expression of IFN-γ+perforin+granzymeB+ in CD8+ T cells. Thus, amiloride is a facilitator for DNA transduction into host cells which in turn enhances the efficiency of the immune responses. © 2012 Geng et al.

Cite

CITATION STYLE

APA

Geng, S., Zhong, Y., Wang, S., Liu, H., Zou, Q., Xie, X., … Wang, B. (2012). Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells. PLoS ONE, 7(3). https://doi.org/10.1371/journal.pone.0033015

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free